作者
Hein Heidbuchel, Peter Verhamme, Marco Alings, Matthias Antz, Hans-Christoph Diener, Werner Hacke, Jonas Oldgren, Peter Sinnaeve, A John Camm, Paulus Kirchhof, Advisors:, Azhar Ahmad, Jutta Heinrich-Nols, Susanne Hess, Markus Müller, Felix Münzel, Markus Schwertfeger, Martin Van Eickels, Isabelle Richard-Lordereau, Gregory YH Lip, Chern-En Chiang, Jonathan Piccini, Tatjana Potpara, Laurent Fauchier, Deirdre Lane, Alvaro Avezum, Torben Bjerregaard Larsen, Guiseppe Boriani, Vanessa Roldan-Schilling, Bulent Gorenek, Irene Savelieva
发表日期
2015/10/1
期刊
Ep Europace
卷号
17
期号
10
页码范围
1467-1507
出版商
Oxford University Press
简介
The current manuscript is an update of the original Practical Guide, published in June 2013[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 2013;15:625–51; Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J 2013;34:2094–106]. Non-vitamin K antagonist oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and patients have to learn how to use these drugs effectively and safely in clinical practice. Many unresolved questions on how to optimally use these drugs in …
学术搜索中的文章
H Heidbuchel, P Verhamme, M Alings, M Antz… - Ep Europace, 2015
H Heidbuchel, P Verhamme, M Alings, M Antz… - European heart journal, 2017